Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPC.L Regulatory News (BPC)

  • There is currently no data for BPC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation of Existing Options, Grant of Options

31 Oct 2019 11:51

RNS Number : 8295R
Bahamas Petroleum Company PLC
31 October 2019
 

31 October 2019

Bahamas Petroleum Company plc

("Bahamas Petroleum" or the "Company")

Cancellation of Existing Options & Grant of Options

At the Annual General Meeting ("AGM") of Bahamas Petroleum Company plc, held on 17th September 2019, shareholders of the Company approved:

 

1. The cancellation of all existing options;

2. The initial grant of 150,000,000 New Options to the Directors, staff and consultants of the Company (out of a total approved pool of 200,000,000 New Options); and

3. The grant of 25,000,000 options pursuant to the Convertible Note Subscription Agreement entered into on 9 October 2019 with Bizzell Capital Partners Pty Ltd and MH Carnegie & Co Pty Ltd.

 

The Company has thus, effective 31 October 2019, proceeded to enact each of these items in accordance with the approvals provided by the Company's shareholders. Full details of each of these items, including the terms of conditions of each, were set out in the Company's Notice of Annual General Meeting (the "Notice"), dated 21 August 2019, and are summarised for the ready information of shareholders in the Appendix to this announcement.

 

 

For further information, please contact:

 

Bahamas Petroleum Company plc

Simon Potter, Chief Executive Officer

 

Tel: +44 (0) 1624 647 882

Strand Hanson Limited - Nomad

Rory Murphy / James Spinney

 

Tel: +44 (0) 20 7409 3494

Shore Capital Stockbrokers Limited

Jerry Keen / Toby Gibbs

Tel: +44 (0) 207 408 4090

CAMARCO

Billy Clegg / James Crothers

Tel: +44 (0) 20 3757 4983

www.bpcplc.com

 

 

Regulatory Statements

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

 

APPENDIX: DETAILS

 

1. Cancellation of Existing Options

 

By agreement with relevant option holders, the Company has, effective 31 October 2019, cancelled all 68.85 million existing options over ordinary shares in the Company, as approved by shareholders at the AGM.

 

2. Grant of New Options to the Directors, staff and consultants of the Company

 

Effective 31 October 2019, New Options have been issued to the Directors, staff and consultants of the Company in three tranches, summarised as follows:

 

(i) Series A: 50,000,000 New Options, fully vested, immediately exercisable, exercise price of 2.22p per New Option (consistent with the exercise price of existing Options being cancelled);

(ii) Series B: 50,000,000 New Options, that will vest and become exercisable at such point in time as the Board, having consulted with the relevant advisers to the Company, determines that the cost of an initial exploration well is fully funded on an unconditional basis, exercise price of 2.4p per New Option;

(iii) Series C: 50,000,000 New Options, that will vest and become exercisable at such point in time as the initial exploration well commences, exercise price of 2.8p per New Option.

 

All New Options, if not exercised, will expire five years after the date of issue. The New Options are not quoted or traded on AIM; on exercise, the Company will make application for the new ordinary shares arising to be admitted for trading on AIM.

 

The New Options have been allocated as follows:

 

OPTIONHOLDER

SERIES A

SERIES B

SERIES C

William Schrader

1,500,000

750,000

750,000

James Smith

750,000

375,000

375,000

Eddie Shallcross*

750,000

375,000

375,000

Ross McDonald

750,000

375,000

375,000

Adrian Collins

750,000

375,000

375,000

Simon Potter

20,000,000

15,000,000

25,000,000

Other executives, employees and consultants, in aggregate

25,500,000

32,750,000

22,750,000

Total:

50,000,000

50,000,000

50,000,000

*Options granted to the estate of Edward Shallcross following his passing away on 14 October 2019

 

3. Grant of options pursuant to the Convertible Note Subscription Agreement

 

Pursuant to the Convertible Note Subscription Agreement entered into on 9 October 2019 with Bizzell Capital Partners Pty Ltd and MH Carnegie & Co Pty Ltd, 25,000,000 options have been granted to these parties with an exercise price of 2 pence per share immediately exercisable for a period of 4 years. Of the total options granted, 6,250,000 options have been granted to Bizzell Capital Partners Pty Ltd and 18,750,000 options have been granted to MH Carnegie & Co Pty Ltd.

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMBBBTMBIJBRL
Date   Source Headline
20th May 202111:00 amRNSResult of Placing and Open Offer and TVR
19th May 20214:51 pmRNSResult of Open Offer and Proposed Placing
17th May 20211:23 pmRNSAppointment of Alternate Director & Result of EGM
13th May 20214:40 pmRNSSecond Price Monitoring Extn
13th May 20214:35 pmRNSPrice Monitoring Extension
13th May 20217:01 amRNSBoard and Management Participation in Fundraising
13th May 20217:00 amRNSProposed New Board Member and Saffron-2 Progress
11th May 20217:00 amRNSExtension of Open Offer Timetable
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 202111:05 amRNSSecond Price Monitoring Extn
6th May 202111:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSSaffron-2 -Rig Mobilisation and Operational Update
23rd Apr 20219:05 amRNSSecond Price Monitoring Extn
23rd Apr 20219:00 amRNSPrice Monitoring Extension
23rd Apr 20217:00 amRNSNotice of Extraordinary General Meeting
7th Apr 20214:40 pmRNSSecond Price Monitoring Extn
7th Apr 20214:35 pmRNSPrice Monitoring Extension
7th Apr 20212:06 pmRNSSecond Price Monitoring Extn
7th Apr 20212:00 pmRNSPrice Monitoring Extension
26th Mar 20217:00 amRNSUpdated Corporate Presentation
24th Mar 20217:00 amRNSHigh-Impact Exploration Update
18th Mar 20217:00 amRNSTrinidad and Tobago and Suriname Update
2nd Mar 20217:00 amRNSUpdate on Court Process in The Bahamas
16th Feb 20217:00 amRNSCorporate and Strategic Update
12th Feb 20214:40 pmRNSSecond Price Monitoring Extn
12th Feb 20214:35 pmRNSPrice Monitoring Extension
12th Feb 20212:06 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSPerseverance #1 - Completion of Drilling
29th Jan 20215:45 pmRNSHolding(s) in Company
26th Jan 20217:00 amRNSIssue of Warrants
25th Jan 20217:10 amRNSResignation of Director
25th Jan 20217:00 amRNSUpdate on Court Process in The Bahamas
21st Jan 20219:05 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20219:30 amRNSHolding(s) in Company
14th Jan 20219:35 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSFunding Strategy: Reconciliation & Put Option
7th Jan 20217:00 amRNSPortfolio Operations and Funding Update
6th Jan 20217:00 amRNSUpdate on Court Process in The Bahamas
5th Jan 202112:29 pmRNSDirector Dealing
31st Dec 20207:00 amRNSFurther Update on Court Process in The Bahamas
30th Dec 20207:00 amRNSUpdate on Court Process in The Bahamas
29th Dec 20207:00 amRNSUpdate on Court Process in The Bahamas
22nd Dec 20201:00 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSExercise and Issuance of Warrants
21st Dec 20207:00 amRNSCommencement of the Drilling of Perseverance #1
16th Dec 20207:00 amRNSFunding Agreements for up to US$20 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.